Oncometabolite <scp>d</scp> -2HG alters T cell metabolism to impair CD8 <sup>+</sup> T cell functionGiulia Notarangelo, Marcia C. Haigis, Jessica B. Spinelli et al.|Science|2022Cited by 271
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Sandro Santagata, Shu Wang et al.|Nature Communications|2022Cited by 88
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Terence Burns et al.|Neuro-Oncology|2021Cited by 81
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña Giménez, Nathalie Y.R. Agar, Ishwar N. Kohale et al.|Neuro-Oncology|2021Cited by 14
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13